Rasburicase (Elitek): a novel agent for tumor lysis syndrome

類似資料

• Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
  著者:: Alakel, Nael, 等
  出版事項: (2017)
• Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
  著者:: Cammalleri, Lisa, 等
  出版事項: (2007)
• Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience
  著者:: TAKAI, MIHOKO, 等
  出版事項: (2015)
• Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase
  著者:: Usami, Eiseki, 等
  出版事項: (2017)
• Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents
  著者:: Cheson, Bruce D., 等
  出版事項: (2017)